Pharmaceuticals
This psychedelic treatment could change the game for concussion sufferers
A new clinical trial is set to test whether psilocybin-assisted psychotherapy could treat the long-term effects of mild traumatic brain injury.
- Bridget McArthur
Latest
‘Back soon’: RFK Jr-inspired health start-up goes offline
Bobbi, a telehealth provider founded by an Australian multimillionaire and named after the US health secretary, has taken down its website after this masthead’s reporting on its prescribing practices.
- Kishor Napier-Raman
- Opinion
- Medicine
As a GP, I’m very worried about changes to how ‘the pill’ will be prescribed
Women in NSW will soon be able to receive the oral contraceptive pill from their pharmacist without seeing a doctor. But increased access should not come at the expense of quality.
- Hayley Glasson
‘Unviable’: 450,000 Australians to miss out on subsidised weight loss drug
Pharmaceutical giant Eli Lilly on Friday declined a recommendation to have the government subsidise its Mounjaro drug for Australians with Type 2 diabetes.
- Angus Thomson
- Updated
- Courts
‘Texts deleted’ before mum accused of smoothie murder
A mother asked her daughter to “keep lookout” while she crushed up a fatal dose of drugs and put them in her brother’s smoothie, a jury has heard.
- Rex Martinich
- Updated
- Trade wars
Trump imposes 100 per cent tariff on Australian drugs – but with caveats
Australia’s largest biotech firm, CSL, could be exempt from the new tariffs, which will not apply to therapies derived from blood plasma in certain circumstances.
- Michael Koziol
‘Backfired’: Ozempic maker’s disastrous trial and its $US475 billion meltdown
Analysts say Novo Nordisk’s new obesity drug may be obsolete before it hits the shelves, underlining a massive fall from grace for the company behind the weight loss boom.
- Colin Kruger
‘My future crumbled’: Amanda joins class action over baby powder’s claimed link to cancer
A class action of 1300 women has started against pharmaceutical giant Johnson & Johnson.
- Kayla Olaya
Boss of $83b giant CSL exits abruptly
Australian pharmaceuticals heavyweight CSL says its chief executive Paul McKenzie is leaving the company with immediate effect.
- Clancy Yeates
Statins don’t cause the majority of ‘side effects’ on the label
These life-saving medications have been blamed for a laundry list of side effects. They’ve just been vindicated.
- Kate Aubusson